Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2020-01-13 Board/Management Inform…
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Zur Rose Group strengthens Group Management: Bernd Gschaider becomes Chief Operations Officer
Board/Management Information Classification · 100% confidence The document is a press release announcing a significant personnel change: the appointment of Bernd Gschaider as the new Chief Operations Officer (COO) of Zur Rose Group. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). The text focuses entirely on the new executive's background and the strategic importance of the role, not on financial results (ER/IR), shareholder votes (DVA), or general regulatory filings (RNS).
2020-01-13 English
Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement
M&A Activity Classification · 99% confidence The document is a press release dated December 27, 2019, announcing the early completion of an earn-out payment related to the acquisition of medpex. The key topic is a financing/capital structure event (settling purchase price components early via a one-off payment) and management changes related to the acquisition. This aligns most closely with the 'Capital/Financing Update' (CAP) category, as it details a significant financial settlement related to a prior acquisition. While it mentions management changes, the primary driver and focus of the announcement is the financial settlement. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV).
2019-12-27 English
Cooperation between Medbase and Zur Rose: The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year
M&A Activity Classification · 99% confidence The document is a 'Press release' dated December 20, 2019, announcing the commencement of operations for two joint ventures between Zur Rose and Medbase concerning shop-in-shop pharmacies and a joint webshop. It is a corporate announcement detailing operational updates and strategic collaborations, not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since it is a general corporate news item about business operations and partnerships, and it does not fit into specific categories like M&A (TAR), Director's Dealing (DIRS), or Capital Changes (CAP), the most appropriate classification is the general regulatory announcement fallback category, RNS, as it is distributed via a news service (EQS Group-News). The document length (4557 chars) is not indicative of a full report, supporting the idea that it is an announcement.
2019-12-20 English
Zur Rose Group AG increases public bond to CHF 200 million
Capital/Financing Update Classification · 99% confidence The document is a press release from Zur Rose Group AG announcing the increase of a public bond from CHF 180 million to CHF 200 million due to strong demand. It details the terms of the bond issuance (amount, coupon, term, price, settlement date, ISIN) and mentions the intended use of proceeds (financing initiatives related to e-prescription in Germany and general corporate purposes). This activity directly relates to the company's fundraising and capital structure changes. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV).
2019-11-01 English
Cooperation between Migros and Zur Rose: Zur Rose and Migros open the first shop-in-shop pharmacy in French-speaking Switzerland
Regulatory Filings Classification · 100% confidence The document is a press release announcing a business cooperation between Zur Rose and Migros to open a shop-in-shop pharmacy. It details a strategic business development, partnership expansion, and operational updates, rather than reporting financial results (ER, IR), providing formal audit information (AR), or announcing a change in management (MANG). Since it is a general corporate announcement about a business development that doesn't fit the specific categories like M&A (TAR) or Capital Change (CAP), it falls best under the general Regulatory Filings (RNS) category, which serves as a fallback for miscellaneous corporate news releases that are not otherwise classified. The document length is moderate (4507 chars), but the content is purely informational news, not a formal regulatory report.
2019-10-29 English
Zur Rose Group AG successfully issues a public straight bond of CHF 180 million
Capital/Financing Update Classification · 99% confidence The document is a press release dated October 24, 2019, announcing that Zur Rose Group AG successfully placed a CHF 180 million public straight bond. This action directly relates to the company's financing activities and capital structure. Based on the definitions, the category 'Capital/Financing Update' (CAP) is the most appropriate classification for an announcement regarding the issuance of a new bond.
2019-10-24 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.